跳至主要内容
临床试验/IRCT20200407046981N46
IRCT20200407046981N46尚未招募未知

Comparative bioequivalence study of the Sertraline 100-mg Tablets manufactured by Modava Company with Sertraline brand tablets (Zoloft®) produced by Pfizer company

Modava Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
Male

入选标准

  • Healthy male volunteers in the age range of 18-60 years old
  • The weight limit of each volunteer should be between 60 and 100 kg.
  • Body mass index should be between18-30
  • All volunteers must be non-smokers
  • They must be healthy in terms of liver, kidney, respiratory system, mental and other general health characteristics that will be assessed
  • Candidates who have consented to the consent form

排除标准

  • Known hypersensitivity or idiosyncratic reaction to Sertralin or any ingredients.
  • Subjects with BP = 90/60 mm/Hg or BP = 140/90 mm/Hg.
  • Taking any medicine during two week before dosing.
  • Any effects of renal, hepatic, cardiac, pulmonary or gastrointestinal dysfunction
  • Any history of tuberculosis, seizures, asthma, diabetes, insanity or glaucoma

研究者

发起方
Modava Pharmaceutical Company

相似试验